Pantoprol

Pantoprol

pantoprazole

Manufacturer:

Exeltis

Distributor:

Biopharm
Concise Prescribing Info
Contents
Pantoprazole
Indications/Uses
Treatment & symptomatic relief of erosive esophagitis in patients w/ GERD. Pathologic GI hypersecretory conditions associated w/ Zollinger-Ellison syndrome or other neoplastic conditions.
Dosage/Direction for Use
IV infusion GERD 40 mg each day for 7-10 days. Pathologic GI hypersecretory conditions 80 mg every 12 hr. May be increased to 80 mg every 8 hr. All doses infused at a rate of 3 mg (7 mL) per min over approx 15 min.
Contraindications
Hypersensitivity to pantoprazole or other substituted benzimidazoles.
Special Precautions
Discontinue if anaphylaxis occurs. May increase risk of developing certain infections (eg, community-acquired pneumonia). Pregnancy & lactation. Childn <18 yr.
Adverse Reactions
Rarely, anaphylaxis, angioedema, chest pain, dyspnea, erythema multiforme, gastroenteritis, hyperglycemia, infection, inj site reaction, jaundice, anterior ischemic optic neuropathy, pancreatitis, speech disorder, Stevens-Johnson syndrome, toxic epidermal necrolysis, UTI.
Drug Interactions
Gastric pH-dependent drugs (eg, ampicillin esters, Fe salts, ketoconazole). INR & prothrombin time may increase w/ warfarin. Sucralfate may delay absorption (administer 30 min before).
ATC Classification
A02BC02 - pantoprazole ; Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
Presentation/Packing
Form
Pantoprol inj (lyo) for soln 40 mg
Packing/Price
1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in